Evidence map›Paper›PMID 36445393›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2023

Follicular CD8+ T Cells Are Elevated in HIV Infection and Induce PD-L1 on B Cells.

Laura E Martínez, Javier Ibarrondo, Yu Guo, Manuel L Penichet, Marta Epeldegui

Open access · bronzeAbstract readMulticenter Study
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. An angel or a devil? Current view on the role of CD8Journal of translational medicine · 2024
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Laura E MartínezAIDS Institute, University of California, Los Angeles, Los Angeles, CA.ORCID 0000-0002-9804-6001
Javier IbarrondoAIDS Institute, University of California, Los Angeles, Los Angeles, CA.ORCID 0000-0002-5973-598X
Yu GuoAIDS Institute, University of California, Los Angeles, Los Angeles, CA.ORCID 0000-0002-9645-9910
Manuel L PenichetAIDS Institute, University of California, Los Angeles, Los Angeles, CA.
Marta EpeldeguiAIDS Institute, University of California, Los Angeles, Los Angeles, CA.ORCID 0000-0002-7605-5994
APLA Health · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
NATURAL HISTORY OF AIDS IN HOMOSEXUAL MENU01AI035040 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DETELS, ROGER, MARTINEZ-MAZA, OTONIEL · 1993 to 2018
$75.2M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KITCHEN, SCOTT G · 1991 to 2018
$39.9M
Sex differences in the role of multi-omicsin HIV-associated carotid artery atherosclerosisU01HL146193 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Stephen J Gange, Elizabeth Topper · 2019 to 2026
$35.8M
Study of Hearing and Balance in Middle Aged and Aging Men and Women in the MACS-WIHS Combined Cohort StudyU01HL146333 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Roger Detels, Matthew James Mimiaga · 2019 to 2026
$32.2M
UCLA Tumor Immunology Training ProgramT32CA009120 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Steven M. Dubinett, MICHAEL A TEITELL · 1985 to 2026
$10.3M
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHLR01CA196266 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MARTINEZ-MAZA, OTONIEL, PENICHET, MANUEL L · 2016 to 2020
$3.4M
The Role of Follicular CD8+ T Cells in Pathogenesis of AIDS-NHL.R01CA228157 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EPELDEGUI, MARTA · 2019 to 2023
$1.8M
PDL1 expression on B cells: a potential marker of pre-tumor cells in AIDS-NHLR21CA220475 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI EPELDEGUI, MARTA · 2017 to 2018
$372k
NCI NIH HHS P30 CA016042NCI NIH HHS R01 CA196266NCI NIH HHS R01 CA228157NCI NIH HHS R21 CA220475NCI NIH HHS T32 CA009120NHLBI NIH HHS U01 HL146193NHLBI NIH HHS U01 HL146333NIAID NIH HHS P30 AI028697NIAID NIH HHS U01 AI035040
6 · The paper itself

Abstract

Follicular CD8+CXCR5+ T cells are a specialized CD8+ T cell subset with unique follicular-homing capabilities that have been reported to display effector functions in viral immunity, tumor immunity, and autoimmunity. CD8+CXCR5+ T cells exhibit B cell helper functions and express CD40L, ICOS, programmed cell death protein 1 (PD-1), and BCL-6, the transcriptional regulator of CD4+CXCR5+ T follicular helper cells and of germinal center B cells. HIV is known to be sequestered in lymphoid follicles, and CD8+CXCR5+ T cell frequency is a marker for disease severity, given that HIV-infected patients with lower numbers of circulating CD8+CXCR5+ T cells display lower CD4+ T cell counts. Likewise, several groups have reported a direct correlation between the quantity of CD8+CXCR5+ T cells and suppression of HIV viral load. In this study, we observed elevated absolute numbers of CD8+CXCR5+ and CD8+CXCR5+BCL-6+PD-1+ T cells in the blood of HIV-infected participants of the Multicenter AIDS Cohort Study. We further demonstrated in vitro that activated human CD8+CXCR5+ T cells isolated from peripheral blood and tonsil from healthy donors show increased CD40L expression and induce the production of PD ligand 1 (PD-L1)+IgG+ B cells. Moreover, absolute numbers of CD8+CXCR5+ T cells significantly and positively correlated with numbers of PD-L1+ B cells found in blood of HIV-infected individuals. Altogether, these results show that activated CD8+CXCR5+ T cells have the ability to activate B cells and increase the percentage of PD-L1+ and PD-L1+IgG+ B cells, which provides insights into the early events of B cell activation and differentiation and may play a role in disease progression and lymphomagenesis in HIV-infected individuals.

Indexed as

HIV InfectionsProgrammed Cell Death 1 ReceptorB7-H1 AntigenCD40 LigandCD8-Positive T-LymphocytesCohort StudiesHumansImmunoglobulin GLigandsReceptors, CXCR5T-Lymphocytes, Helper-InducerB7-H1 AntigenCD40 LigandImmunoglobulin GLigandsProgrammed Cell Death 1 ReceptorReceptors, CXCR5

Identifiers

PMID36445393
PMCPMC9840893
OpenAlexW4310467782

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.